FASENRA 30MG/1ML INJECTION

FASENRA 30MG/1ML INJECTION is administered as a subcutaneous injection (under the skin). The frequency and dosing may vary depending on the specific treatment regimen prescribed by a healthcare provider. It is usually given once every 4 to 8 weeks.

FASENRA 30MG/1ML INJECTION is not a cure for asthma. It is a medication designed to help manage and control severe eosinophilic asthma by reducing airway inflammation and symptoms. While it can significantly improve the quality of life for many people with severe asthma, it does not eliminate the underlying condition, and treatment may need to be continued as long as the condition persists.

FASENRA 30MG/1ML INJECTION is approved for use in adolescents aged 12 years and older with severe eosinophilic asthma. Its safety and efficacy in younger children have not been established, so it is generally not prescribed for those below the approved age range.

FASENRA 30MG/1ML INJECTION is available in injection form. The specific formulation and dosing will depend on the individual's condition and the healthcare provider's recommendation.

FASENRA 30MG/1ML INJECTION may not be suitable for everyone. Individuals with known hypersensitivity or allergy to it or its components should not use it. It is important to inform your physician of any other medical conditions or medications you are taking before starting the treatment.

FASENRA 30MG/1ML INJECTION may not be suitable for everyone. Individuals with known hypersensitivity or allergy to it or its components should not use it. It is important to inform your physician of any other medical conditions or medications you are taking before starting the treatment.

Information regarding the specific interactions of FASENRA 30MG/1ML INJECTION with other drugs should be discussed with your healthcare provider or pharmacist. It is important to inform them of all medications you are currently taking, including prescription, over-the-counter, and herbal supplements.

Before starting FASENRA 30MG/1ML INJECTION, your doctor will likely assess your medical history and perform any necessary tests to determine if it is a suitable treatment for your specific condition. They will also provide you with instructions on how to take the medication properly and monitor your progress during treatment.

The active ingredient in FASENRA 30MG/1ML INJECTION is Benralizumab.